19-43506795-C-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BA1BS2

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.55G>T variant in the ETHE1 gene is >0.7% by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Mito Variant Curation Expert Panel (BA1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA10652049/MONDO:0011229/014

Frequency

Genomes: 𝑓 0.0015 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0022 ( 14 hom. )

Consequence

ETHE1
NM_014297.5 3_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel U:2B:2

Conservation

PhyloP100: 0.994

Publications

0 publications found
Variant links:
Genes affected
ETHE1 (HGNC:23287): (ETHE1 persulfide dioxygenase) This gene encodes a member of the metallo beta-lactamase family of iron-containing proteins involved in the mitochondrial sulfide oxidation pathway. The encoded protein catalyzes the oxidation of a persulfide substrate to sulfite. Certain mutations in this gene cause ethylmalonic encephalopathy, an infantile metabolic disorder affecting the brain, gastrointestinal tract and peripheral vessels. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2016]
ETHE1 Gene-Disease associations (from GenCC):
  • ethylmalonic encephalopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ETHE1NM_014297.5 linkc.*55G>T 3_prime_UTR_variant Exon 7 of 7 ENST00000292147.7 NP_055112.2 O95571A0A0S2Z5B3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ETHE1ENST00000292147.7 linkc.*55G>T 3_prime_UTR_variant Exon 7 of 7 1 NM_014297.5 ENSP00000292147.1 O95571
ETHE1ENST00000594342.5 linkn.*383G>T non_coding_transcript_exon_variant Exon 6 of 6 2 ENSP00000469652.1 M0QY80
ETHE1ENST00000594342.5 linkn.*383G>T 3_prime_UTR_variant Exon 6 of 6 2 ENSP00000469652.1 M0QY80

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
226
AN:
152110
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000590
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00622
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00191
Gnomad OTH
AF:
0.000956
GnomAD4 exome
AF:
0.00224
AC:
3104
AN:
1384064
Hom.:
14
Cov.:
22
AF XY:
0.00251
AC XY:
1738
AN XY:
692622
show subpopulations
African (AFR)
AF:
0.000377
AC:
12
AN:
31860
American (AMR)
AF:
0.000740
AC:
33
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.00207
AC:
53
AN:
25644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39286
South Asian (SAS)
AF:
0.00735
AC:
622
AN:
84634
European-Finnish (FIN)
AF:
0.00355
AC:
188
AN:
52908
Middle Eastern (MID)
AF:
0.0146
AC:
65
AN:
4450
European-Non Finnish (NFE)
AF:
0.00190
AC:
1982
AN:
1042944
Other (OTH)
AF:
0.00258
AC:
149
AN:
57756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
158
316
475
633
791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00148
AC:
226
AN:
152228
Hom.:
3
Cov.:
31
AF XY:
0.00148
AC XY:
110
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41542
American (AMR)
AF:
0.000589
AC:
9
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00622
AC:
30
AN:
4820
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00191
AC:
130
AN:
68014
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000318
Hom.:
0
Bravo
AF:
0.00134
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Ethylmalonic encephalopathy Uncertain:2Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

May 18, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2020
ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The filtering allele frequency of the c.55G>T variant in the ETHE1 gene is >0.7% by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Mito Variant Curation Expert Panel (BA1) -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.3
DANN
Benign
0.48
PhyloP100
0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201842186; hg19: chr19-44010947; API